PANACEA PHARMACY LIMITEDActive

Company number 02994714Private limited companyIncorporated 1994

Key figures

£1,277,413+0.7%
Net assets 2024/25
+3.6%
Average annual growth 2019/20–2024/25
0500 k1 m1.5 m2019/202020/212021/222022/232023/242024/25

Like most small UK companies, PANACEA PHARMACY LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0500 k1 m1.5 m2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand192,541307,60795,630207,78710,353
Total assets1,490,5021,484,9951,387,1551,493,7751,467,726
Total liabilities333,973273,301136,455224,766190,313
Net assets / total equity1,156,5291,211,6941,250,7001,269,0091,277,413
Average number of employees00226

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: PANACEA PHARMACY LIMITED

Company

PANACEA PHARMACY LIMITED is a private limited company registered with Companies House under company number 02994714. It was incorporated on 25 Nov 1994. Its status is active. The registered office is in Leeds (LS26). Its nature of business (SIC 2007) is dispensing chemist in specialised stores (47730).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Jul 2025); the company files abridged accounts (unaudited). Net assets were £1,277,413, up 0.7% on the previous year. Cash at bank and in hand was £10,353. Total assets were £1,467,726 and total liabilities £190,313. The company had an average of 6 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered. 4 of 4 registered charges are outstanding.

Filing deadlines

The next accounts are due by 30 Apr 2027. The next confirmation statement is due by 9 Dec 2026.